Work

Figure 4 from Ex Vivo Tumor-Derived Organoid Pharmacotyping Identifies Personalized Therapeutic Options for Patients with Biliary Tract Cancer

Year: 2026

Type: other

Abstract: OncoPrint for the BTC cohort. All structural rearrangements, pathogenic mutations, copy gains, and copy losses of genes taken from clinical histories and third-party NGS sequencing for the BTC cohort are noted. VUSs are not included.

DOI: 10.1158/2767-9764.33395324

Authors: Annie Blair Richardson, Payel Chatterjee, Rachele Rosati, Alex Rajewski, Robert L. Diaz, Lauren R. Appleyard, Shalini Pereira, Brady Bernard, Milind M. Javle, Gentry G. King, Adam Diehl, William Proctor Harris, Sameek Roychowdhury, Christopher J. Kemp, Carla Grandori

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7204772854

Cites:

Cited by:

Related to: 10